Resistance to 17 antimicrobials, surface hydrophobicity, motility, biofilm, production of N-acylhomoserine lactone signal molecules (N-butyrylhomoserine lactone and N-3-oxolauroylhomoserine lactone) and response to oxidative stress were analyzed in 47 clinical Pseudomonas aeruginosa strains. In addition to natural resistance, the strains demonstrated the greatest level of resistance to cefotaxime (91.5%). Isolates in the range of 44.7-57.4% were resistant to aminoglycosides and ciprofloxacin, of 25.5-36.2% to cephalosporins. On the other hand, 97.9% remained susceptible to meropenem, 93.6% to piperacillin + tazobactam and 87.2% to piperacillin. The majority of the strains (72.3%) manifested their hydrophilic character. Higher zones of motility showed 12 isolates (in average 54.8 mm) as compared to the others (30.2 mm). Approximately 1/3 of the strains (29.8%) produced a higher amount of biofilm quantified by measuring the absorbance of solubilized crystal violet (0.20-0.46) than the rest of isolates (0-0.19). All but two strains produced N-3-oxolauroylhomoserine lactone and in 48.9% of samples N-butyrylhomoserine lactone were detected. Only four isolates with higher biofilm production showed both types of homoserine lactone. Majority of the strains (70.2%) manifested higher resistance to H2O2 than the rest of the strains. The group of strains resistant to aminoglycosides and ciprofloxacin revealed a significantly higher number of hydrophobic strains (compared with the sensitive ones). In contrast, higher number of strains sensitive to aminoglycosides and ciprofloxacin or only to ciprofloxacin produced N-butyrylhomoserine lactone and biofilm (compared to the resistant ones). Such association was not found among the rest of the tested parameters. The results indicate that the resistance to antimicrobials in P. aeruginosa isolates was not generally associated with changes in the production of the pathogenicity factors.

Slovak Medical University Bratislava Slovakia

Zobrazit více v PubMed

J Antimicrob Chemother. 2000 Jan;45(1):15-25 PubMed

J Antimicrob Chemother. 2002 Apr;49(4):651-9 PubMed

Folia Microbiol (Praha). 2005;50(2):99-102 PubMed

J Bacteriol. 2001 Sep;183(18):5213-22 PubMed

Int J Antimicrob Agents. 2001 Dec;18(6):567-70 PubMed

Int J Antimicrob Agents. 2000 Dec;16(4):395-400 PubMed

J Infect Dis. 2004 Jul 1;190(1):136-47 PubMed

Science. 1998 Apr 10;280(5361):295-8 PubMed

J Infect Dis. 1991 Jan;163(1):143-9 PubMed

Folia Microbiol (Praha). 2004;49(1):75-8 PubMed

Annu Rev Microbiol. 1996;50:727-51 PubMed

Chemotherapy. 2000 Jul-Aug;46(4):229-34 PubMed

Microbes Infect. 2004 Sep;6(11):1043-8 PubMed

Folia Microbiol (Praha). 1994;39(4):337-41 PubMed

J Appl Microbiol. 2004;96(1):177-84 PubMed

Pathol Biol (Paris). 2000 Jun;48(5):472-7 PubMed

Mol Microbiol. 1998 Oct;30(2):295-304 PubMed

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):782-6 PubMed

Mol Microbiol. 1998 May;28(3):449-61 PubMed

J Infect Dis. 1961 Mar-Apr;108:218-28 PubMed

Folia Microbiol (Praha). 2004;49(6):757-62 PubMed

Diagn Microbiol Infect Dis. 2001 Feb;39(2):105-16 PubMed

Folia Microbiol (Praha). 2004;49(4):465-70 PubMed

Folia Microbiol (Praha). 1993;38(5):415-20 PubMed

J Microbiol Methods. 2001 Apr;44(3):239-51 PubMed

Nature. 2000 Oct 12;407(6805):762-4 PubMed

Paediatr Drugs. 2000 Nov-Dec;2(6):451-63 PubMed

Folia Microbiol (Praha). 2003;48(4):529-33 PubMed

Eur J Clin Microbiol Infect Dis. 2000 May;19(5):370-4 PubMed

J Bacteriol. 1995 Nov;177(22):6330-7 PubMed

FEMS Microbiol Lett. 2000 Oct 1;191(1):31-6 PubMed

Crit Care Med. 1999 Aug;27(8):1421-8 PubMed

Kansenshogaku Zasshi. 1997 Dec;71(12):1181-6 PubMed

Folia Microbiol (Praha). 2002;47(4):445-9 PubMed

Emerg Infect Dis. 1998 Oct-Dec;4(4):551-60 PubMed

Changes in Galleria mellonella lysozyme level and activity during Pseudomonas aeruginosa infection

Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa

Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Portuguese Central Hospital

Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital

Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains